This study is examining the effectiveness of a new antibiotic for treatment of UTI as compared to Augmentin. Patients with UTIs will receive either Augmentin or the study medication for treatment of their UTI. There is no placebo in this study. Participants should be female, aged 18 and older, and have UTI symptoms that have started no more than 4 days prior to screening for the study. This study lasts 4 weeks, with 4 visits. Compensation is $75 per completed visit.
Female patients aged 18 years and older
Experiencing symptoms of UTI that began in the past 4 days
Diagnosed with active UTI at screening visit
6210 Brandt Pike, Suite 102
Dayton, Ohio 45424